Engineering principles of clinical cell-based tissue engineering
- PMID: 15252108
- DOI: 10.2106/00004623-200407000-00029
Engineering principles of clinical cell-based tissue engineering
Abstract
Tissue engineering is a rapidly evolving discipline that seeks to repair, replace, or regenerate specific tissues or organs by translating fundamental knowledge in physics, chemistry, and biology into practical and effective materials, devices, systems, and clinical strategies. Stem cells and progenitors that are capable of forming new tissue with one or more connective tissue phenotypes are available from many adult tissues and are defined as connective tissue progenitors. There are four major cell-based tissue-engineering strategies: (1) targeting local connective tissue progenitors where new tissue is desired, (2) transplanting autogenous connective tissue progenitors, (3) transplanting culture-expanded or modified connective tissue progenitors, and (4) transplanting fully formed tissue generated in vitro or in vivo. Stem cell function is controlled by changes in stem cell activation and self-renewal or by changes in the proliferation, migration, differentiation, or survival of the progeny of stem cell activation, the downstream progenitor cells. Three-dimensional porous scaffolds promote new tissue formation by providing a surface and void volume that promotes the attachment, migration, proliferation, and desired differentiation of connective tissue progenitors throughout the region where new tissue is needed. Critical variables in scaffold design and function include the bulk material or materials from which it is made, the three-dimensional architecture, the surface chemistry, the mechanical properties, the initial environment in the area of the scaffold, and the late scaffold environment, which is often determined by degradation characteristics. Local presentation or delivery of bioactive molecules can change the function of connective tissue progenitors (activation, proliferation, migration, differentiation, or survival) in a manner that results in new or enhanced local tissue formation. All cells require access to substrate molecules (oxygen, glucose, and amino acids). A balance between consumption and local delivery of these substrates is needed if cells are to survive. Transplanted cells are particularly vulnerable. Theoretical calculations can be used to explore the relationships among cell density, diffusion distance, and cell viability within a graft and to design improved strategies for transplantation of connective tissue progenitors. Rational strategies for tissue engineering seek to optimize new tissue formation through the logical selection of conditions that modulate the performance of connective tissue progenitors in a graft site to produce a desired tissue. This increasingly involves strategies that combine cells, matrices, inductive stimuli, and techniques that enhance the survival and performance of local or transplanted connective tissue progenitors.
Similar articles
-
Cellular strategies for enhancement of fracture repair.J Bone Joint Surg Am. 2008 Feb;90 Suppl 1:111-9. doi: 10.2106/JBJS.G.01572. J Bone Joint Surg Am. 2008. PMID: 18292365 Review.
-
Connective tissue progenitors: practical concepts for clinical applications.Clin Orthop Relat Res. 2002 Feb;(395):66-80. doi: 10.1097/00003086-200202000-00008. Clin Orthop Relat Res. 2002. PMID: 11937867 Review.
-
Functional liver tissue engineering by an adult mouse liver-derived neuro-glia antigen 2-expressing stem/progenitor population.J Tissue Eng Regen Med. 2018 Jan;12(1):e190-e202. doi: 10.1002/term.2311. Epub 2017 May 23. J Tissue Eng Regen Med. 2018. PMID: 27638002
-
Human endothelial colony-forming cells expanded with an improved protocol are a useful endothelial cell source for scaffold-based tissue engineering.J Tissue Eng Regen Med. 2015 Nov;9(11):E84-97. doi: 10.1002/term.1673. Epub 2013 Feb 25. J Tissue Eng Regen Med. 2015. PMID: 23436759
-
Tissue engineering using human embryonic stem cells.Methods Enzymol. 2006;420:303-15. doi: 10.1016/S0076-6879(06)20014-4. Methods Enzymol. 2006. PMID: 17161703
Cited by
-
Biomaterials for Bone Regenerative Engineering.Adv Healthc Mater. 2015 Jun 24;4(9):1268-85. doi: 10.1002/adhm.201400760. Epub 2015 Apr 7. Adv Healthc Mater. 2015. PMID: 25846250 Free PMC article. Review.
-
EFFECT OF USE OF BONE-MARROW CENTRIFUGATE ON MUSCLE INJURY TREATMENT: EXPERIMENTAL STUDY ON RABBITS.Rev Bras Ortop. 2015 Nov 16;46(6):718-25. doi: 10.1016/S2255-4971(15)30331-1. eCollection 2011 Nov-Dec. Rev Bras Ortop. 2015. PMID: 27047832 Free PMC article.
-
Wnt3a reestablishes osteogenic capacity to bone grafts from aged animals.J Bone Joint Surg Am. 2013 Jul 17;95(14):1278-88. doi: 10.2106/JBJS.L.01502. J Bone Joint Surg Am. 2013. PMID: 23864176 Free PMC article.
-
Longitudinal in vivo imaging to assess blood flow and oxygenation in implantable engineered tissues.Tissue Eng Part C Methods. 2012 Sep;18(9):697-709. doi: 10.1089/ten.TEC.2011.0744. Epub 2012 May 21. Tissue Eng Part C Methods. 2012. PMID: 22435776 Free PMC article.
-
Endothelial/Mesenchymal Stem Cell Crosstalk Within Bioprinted Cocultures.Tissue Eng Part A. 2020 Mar;26(5-6):339-349. doi: 10.1089/ten.TEA.2019.0175. Epub 2019 Oct 29. Tissue Eng Part A. 2020. Retraction in: Tissue Eng Part A. 2020 Jun;26(11-12):683. doi: 10.1089/ten.tea.2019.0175.retract. PMID: 31559923 Free PMC article. Retracted.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources